ArticleAntibiotics (Basel, Switzerland)2022

Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against

Federica Bovo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.